Re: Sabizabulin - mCRPC- used now for Covid 19.
in response to
by
posted on
Apr 18, 2022 12:02PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Unless Zenith was to get a new, competent, CEO my hope would just be for an outright sale of the company. I don't think we would see close to fair value on an IPO based on a licensing model managed by leadership that has not been able to create value from previous opportunity. JMO